BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3253 related articles for article (PubMed ID: 15546892)

  • 1. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pre-emptive re-transplant in graft and recipient outcome.
    Goldfarb-Rumyantzev AS; Hurdle JF; Baird BC; Stoddard G; Wang Z; Scandling JD; Barenbaum LL; Cheung AK
    Nephrol Dial Transplant; 2006 May; 21(5):1355-64. PubMed ID: 16476722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between recipient alcohol dependency and long-term graft and recipient survival.
    Gueye AS; Chelamcharla M; Baird BC; Nguyen C; Tang H; Barenbaum AL; Koford JK; Shihab F; Goldfarb-Rumyantzev AS
    Nephrol Dial Transplant; 2007 Mar; 22(3):891-8. PubMed ID: 17172252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors.
    Mange KC; Joffe MM; Feldman HI
    N Engl J Med; 2001 Mar; 344(10):726-31. PubMed ID: 11236776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study.
    Lee CK; Christensen LL; Magee JC; Ojo AO; Harmon WE; Bridges ND
    J Heart Lung Transplant; 2007 May; 26(5):458-65. PubMed ID: 17449414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of pretransplant renal replacement therapy duration with outcome in kidney transplant recipients: a prevalent cohort study in Slovenia.
    Arnol M; Buturović-Ponikvar J; Kandus A
    Ther Apher Dial; 2011 Jun; 15(3):234-9. PubMed ID: 21624068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplant outcomes in patients with Fabry disease.
    Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
    Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of myocardial infarction after kidney transplantation.
    Lentine KL; Brennan DC; Schnitzler MA
    J Am Soc Nephrol; 2005 Feb; 16(2):496-506. PubMed ID: 15615820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and enrollment on the renal transplant waiting list in the United States.
    Abbott KC; Glanton CW; Agodoa LY
    J Nephrol; 2003; 16(1):40-8. PubMed ID: 12649534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
    Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
    Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dialysis duration and modality on kidney transplant outcomes.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):837-9. PubMed ID: 19376365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 163.